Zyversa Therapeutics Inc.

07/28/2025 | Press release | Distributed by Public on 07/28/2025 05:56

Material Event (Form 8-K)

Item 8.01 Other Events.

On July 25, 2025, the OTC Markets Group notified ZyVersa Therapeutics, Inc. (the "Company") that its common stock has been approved for quotation on the OTCQB Venture Market ("OTCQB"). The Company expects that trading of the Company's common stock on OTCQB will commence at the open of trading on July 28, 2025, under its current trading symbol "ZVSA."

Zyversa Therapeutics Inc. published this content on July 28, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on July 28, 2025 at 11:56 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]